Dr Edwin Y Endo, OD | |
98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 | |
(808) 487-5500 | |
(808) 486-2694 |
Full Name | Dr Edwin Y Endo |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 44 Years |
Location | 98-1247 Kaahumanu St, Aiea, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861471674 | NPI | - | NPPES |
0000PCBQF | Other | HI | MEDICARE INDIVIDUAL |
04604501 | Medicaid | HI | |
HEENDO | Other | HI | MEDICARE GROUP PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 149 (Hawaii) | Primary |
Provider Name | Edwin Yoshio Endo |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1538464011 PECOS PAC ID: 1951291699 Enrollment ID: O20120521000083 |
News Archive
Republican lawmakers are refocusing their election-year political efforts on hammering the health law's unpopularity even as the agenda for getting legislation done shrinks amid a tightening political climate, which could stall immigration and unemployment benefit measures.
The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."
IPC The Hospitalist Company, Inc., the leading national hospitalist physician group practice company, announced today that it has acquired Premier Hospitalists, Inc., headquartered in St. Louis, Missouri.
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Edwin Y Endo, OD 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 Ph: (808) 487-5500 | Dr Edwin Y Endo, OD 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701-5300 Ph: (808) 487-5500 |
News Archive
Republican lawmakers are refocusing their election-year political efforts on hammering the health law's unpopularity even as the agenda for getting legislation done shrinks amid a tightening political climate, which could stall immigration and unemployment benefit measures.
The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."
IPC The Hospitalist Company, Inc., the leading national hospitalist physician group practice company, announced today that it has acquired Premier Hospitalists, Inc., headquartered in St. Louis, Missouri.
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
› Verified 4 days ago
Styleyes Optometrist Medicare: Medicare Enrolled Practice Location: 98-150 Kaonohi St, B211, Aiea, HI 96701 Phone: 808-486-3937 Fax: 808-486-3386 | |
Dr. Melanie Keiko Nakashima, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St, Ste 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-486-2694 | |
Dr. Walter M Yamamoto, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-205 Moanalua Rd, Ste 210, Aiea, HI 96701 Phone: 808-487-1010 Fax: 808-488-3433 | |
Mr. Edwin Yoshio Endo Ii, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 98-1247 Kaahumanu St, Suite 105, Aiea, HI 96701 Phone: 808-487-5500 Fax: 808-488-2322 | |
Isaac J. Kaopua Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 98-1247 Kaahumanu St, Suite #116, Aiea, HI 96701 Phone: 808-488-4000 Fax: 808-488-7667 | |
Dr. Walter Gwok Wo Au, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St Ste 105, Aiea, HI 96701 Phone: 808-487-5500 | |
Marissa Matsuyama, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 99-128 Aiea Heights Dr Ste 703, Aiea, HI 96701 Phone: 808-487-7938 |